AstraZeneca

AZNCF | OTC

Price Alert Chart Builder DCF Calculator

$189.90

-$2.60 (-1.35%)

Mar 13, 2026, 9:30 AM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020	FY 2019 Dec 30, 2019
Revenue	54.07B	45.81B	44.35B	37.42B	26.62B	24.38B
Cost of Revenue	10.21B	8.27B	12.39B	12.44B	5.3B	4.92B
Gross Profit	43.87B	37.54B	31.96B	24.98B	21.32B	19.46B
Operating Income	10B	8.19B	3.76B	1.06B	5.16B	2.92B
Interest Income	331.91M	298.01M	95M	43M	87M	172M
Pretax Income	8.69B	6.9B	2.5B	-265M	3.92B	1.55B
Net Income	7.04B	5.96B	3.29B	112M	3.2B	1.34B
Selling & General & Admin	20.22B	18.22B	18.96B	15.68B	11.69B	11.44B
Research & Development	13.58B	10.94B	9.76B	9.74B	5.99B	5.96B
Other Expenses	56M	193M	n/a	-46.2M	11.73M	4.15M
Operating Expenses	33.86B	29.35B	28.2B	23.92B	16.16B	16.27B
Interest Expense	1.36B	1.59B	1.35B	1.3B	1.31B	1.43B
Selling & Marketing Expenses	555M	539M	18.96B	15.68B	11.69B	339M
Cost & Expenses	44.07B	37.62B	40.59B	36.36B	21.46B	21.19B
Income Tax Expense	1.65B	938M	-792M	-380M	772M	321M
Shares Outstanding (Basic)	1.55B	1.55B	1.55B	1.42B	1.31B	1.3B
Shares Outstanding (Diluted)	1.56B	1.56B	1.56B	1.43B	1.31B	1.3B
EPS (Basic)	4.54	3.84	2.09	0.08	2.60	1.07
EPS (Diluted)	4.50	3.81	2.07	0.08	2.59	1.07
EBITDA	15.44B	13.91B	9.09B	5.11B	8.08B	6.71B
EBIT	10.37B	8.53B	3.83B	1.01B	5.19B	2.95B
Depreciation & Amortization	5.07B	5.39B	5.16B	4.03B	3.09B	2.89B